**BACKGROUND:** Botulinum toxin type A has been shown to be a promising therapy for hypertrophic scars by alleviating muscle tension, inhibiting fibroblasts proliferation, and influencing transforming growth factor-β1 expression.^1^ However, persistent inflammation in wound healing is one of the main causes of hypertrophic scars.^2^ The severity of the inflammatory response is determined in large part by pro-inflammatory M1 macrophages.^3^ Studies have reported that botulinum toxin type A had an anti-inflammatory effect and could induce innate immune cell activation such as macrophages.^4^ Therefore, we hypothesized that botulinum toxin type A may reduce inflammation and inhibited the hypertrophic scars formation by preventing macrophage M1 polarization.

**MATERIALS AND METHODS:** Murine macrophage RAW264.7 cells were cultured and treated with LPS (to induce M1 polarization) and botulinum toxin type A for 24 hours. M1-type markers such as iNOS, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were determined by reverse transcription-quantitative polymerase chain reaction. The mouse model of hypertrophic scars was prepared by a mechanical stretch device^5^ and treated with botulinum toxin type A. Histologic studies were performed to evaluate scar hypertrophy by hematoxylin and eosin and Masson's trichrome staining. The pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 were observed by immunohistochemistry. The M1 macrophages (F4/80^+^ iNOS^+^ cells) in vivo were further evaluated by immunofluorescence staining.

**RESULTS:** The mRNA levels of iNOS, TNF-α, IL-1β, and IL-6 of RAW264.7 cells were significantly decreased in the botulinum toxin type A treated group than in the controls. In addition, histologic studies and immunohistochemistry showed that local administration of botulinum toxin type A significantly inhibited hypertrophic scars formation and reduced inflammatory response with decreased expression of TNF-α, IL-1β, and IL-6. Besides, botulinum toxin type A administration led to a decrease in the percentage of M1 macrophages in the scar tissue.

**CONCLUSION:** Botulinum toxin type A inhibits macrophage M1 polarization during wound healing and attenuates hypertrophic scars formation.
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